Neurotech International Limited (ASX:NTI) Insider Robert (Max) Johnston Acquires 500,000 Shares

Neurotech International Limited (ASX:NTIGet Free Report) insider Robert (Max) Johnston purchased 500,000 shares of the stock in a transaction on Tuesday, May 7th. The shares were acquired at an average price of A$0.09 ($0.06) per share, for a total transaction of A$45,000.00 ($29,801.32).

Neurotech International Stock Performance

The company has a current ratio of 18.38, a quick ratio of 3.36 and a debt-to-equity ratio of 1.05.

About Neurotech International

(Get Free Report)

Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies.

Read More

Receive News & Ratings for Neurotech International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neurotech International and related companies with MarketBeat.com's FREE daily email newsletter.